Patterns of use and adverse events reported among persons who regularly inject buprenorphine: a systematic review
Abstract Background and Aims Given the ongoing opioid crisis, novel interventions to treat severe opioid use disorder (OUD) are urgently needed. Injectable opioid agonist therapy (iOAT) with diacetylmorphine or hydromorphone is effective for the treatment of severe, treatment-refractory OUD, however...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-10-01
|
Series: | Harm Reduction Journal |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12954-022-00695-5 |